Related Articles
THE EFFECT OF LOW-DOSE OKT3 MONOCLONAL-ANTIBODY THERAPY ON K562 CYTOTOXICITY IN HUMAN CANCER-PATIENTS
CD5-mediated inhibition of TCR signaling proceeds normally in the absence of SHP-1
Characterization of cytomegalovirus pp65-HLA-A24 peptide-specific CTL lines from metastatic melanoma patients
Large scale ex vivo expansion of clinical‑grade effector cells for adoptive immunotherapy
Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients